# Northrim Bancorp Inc: financial statements, quarterly

NRIM · Nasdaq · CIK 1163370 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nrim.md) · [Financials](/companies/nrim/financials.md) · [Filings](/companies/nrim/filings.md) · [Insiders](/companies/nrim/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nrim/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [43.7](/filings/0001163370-25-000017.md) | [46.5](/filings/0001163370-25-000029.md) | [51.0](/filings/0001163370-25-000043.md) | [54.8 d](/filings/0001163370-26-000007.md) | [54.6](/filings/0001163370-26-000021.md) | [61.4](/filings/0001163370-26-000029.md) | [77.2](/filings/0001163370-25-000043.md) | [62.3 d](/filings/0001163370-26-000007.md) | [59.8](/filings/0001163370-26-000021.md) | [63.9](/filings/0001163370-26-000029.md) |
| Gross profit | $m | not reported | not reported | [34.1](/filings/0001163370-25-000017.md) | [36.8](/filings/0001163370-25-000029.md) | [38.4](/filings/0001163370-25-000043.md) | [42.7 d](/filings/0001163370-26-000007.md) | [45.7](/filings/0001163370-26-000021.md) | [48.3](/filings/0001163370-26-000029.md) | [64.9](/filings/0001163370-25-000043.md) | [50.0 d](/filings/0001163370-26-000007.md) | [48.6](/filings/0001163370-26-000021.md) | [52.2](/filings/0001163370-26-000029.md) |
| Interest expense | $m | [8.1](/filings/0001163370-23-000049.md) | [9.2 d](/filings/0001163370-24-000010.md) | [9.4](/filings/0001163370-24-000026.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.9](/filings/0001163370-24-000037.md) | [1.7 d](/filings/0001163370-26-000007.md) | [2.3](/filings/0001163370-25-000017.md) | [2.5](/filings/0001163370-25-000029.md) | [2.8](/filings/0001163370-25-000043.md) | [2.4 d](/filings/0001163370-26-000007.md) | [4.3](/filings/0001163370-26-000021.md) | [4.0](/filings/0001163370-26-000029.md) | [7.5](/filings/0001163370-25-000043.md) | [4.2 d](/filings/0001163370-26-000007.md) | [4.3](/filings/0001163370-26-000021.md) | [4.9](/filings/0001163370-26-000029.md) |
| Net income | $m | [8.4](/filings/0001163370-24-000037.md) | [6.6](/filings/0001163370-24-000037.md) | [8.2](/filings/0001163370-25-000043.md) | [9.0](/filings/0001163370-25-000043.md) | [8.8](/filings/0001163370-25-000043.md) | [10.9](/filings/0001163370-25-000043.md) | [13.3](/filings/0001163370-26-000029.md) | [11.8](/filings/0001163370-26-000029.md) | [27.1](/filings/0001163370-26-000029.md) | [12.4](/filings/0001163370-26-000029.md) | [13.7](/filings/0001163370-26-000029.md) | [15.3](/filings/0001163370-26-000029.md) |
| Diluted EPS | $ per share | [1.48](/filings/0001163370-24-000037.md) | not reported | [1.48](/filings/0001163370-25-000017.md) | [1.62](/filings/0001163370-25-000029.md) | [0.39](/filings/0001163370-25-000043.md) | not reported | [0.60](/filings/0001163370-26-000021.md) | [0.52](/filings/0001163370-26-000029.md) | [1.20](/filings/0001163370-25-000043.md) | not reported | [0.61](/filings/0001163370-26-000021.md) | [0.68](/filings/0001163370-26-000029.md) |
| Basic EPS | $ per share | [1.50](/filings/0001163370-24-000037.md) | not reported | [1.49](/filings/0001163370-25-000017.md) | [1.64](/filings/0001163370-25-000029.md) | [0.40](/filings/0001163370-25-000043.md) | not reported | [0.60](/filings/0001163370-26-000021.md) | [0.53](/filings/0001163370-26-000029.md) | [1.23](/filings/0001163370-25-000043.md) | not reported | [0.62](/filings/0001163370-26-000021.md) | [0.69](/filings/0001163370-26-000029.md) |

- Revenue: us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,790](/filings/0001163370-23-000049.md) | [2,807](/filings/0001163370-26-000007.md) | [2,760](/filings/0001163370-24-000026.md) | [2,822](/filings/0001163370-24-000032.md) | [2,963](/filings/0001163370-24-000037.md) | [3,042](/filings/0001163370-26-000007.md) | [3,141](/filings/0001163370-25-000017.md) | [3,244](/filings/0001163370-25-000029.md) | [3,312](/filings/0001163370-25-000043.md) | [3,290](/filings/0001163370-26-000029.md) | [3,355](/filings/0001163370-26-000021.md) | [3,415](/filings/0001163370-26-000029.md) |
| Total liabilities | $m | [2,565](/filings/0001163370-23-000049.md) | [2,573](/filings/0001163370-25-000007.md) | [2,520](/filings/0001163370-24-000026.md) | [2,574](/filings/0001163370-24-000032.md) | [2,703](/filings/0001163370-24-000037.md) | [2,775](/filings/0001163370-26-000007.md) | [2,861](/filings/0001163370-25-000017.md) | [2,954](/filings/0001163370-25-000029.md) | [2,997](/filings/0001163370-25-000043.md) | [2,964](/filings/0001163370-26-000029.md) | [3,019](/filings/0001163370-26-000021.md) | [3,068](/filings/0001163370-26-000029.md) |
| Long-term debt | $m | not reported | [13.7](/filings/0001163370-24-000010.md) | not reported | not reported | not reported | [23.0](/filings/0001163370-25-000007.md) | not reported | not reported | not reported | [81.7](/filings/0001163370-26-000029.md) | [81.7](/filings/0001163370-26-000021.md) | [81.6](/filings/0001163370-26-000029.md) |
| Shareholders' equity | $m | [225](/filings/0001163370-24-000037.md) | [235](/filings/0001163370-26-000007.md) | [239](/filings/0001163370-25-000043.md) | [247](/filings/0001163370-25-000043.md) | [260](/filings/0001163370-25-000043.md) | [267](/filings/0001163370-26-000029.md) | [280](/filings/0001163370-26-000029.md) | [290](/filings/0001163370-26-000029.md) | [316](/filings/0001163370-26-000029.md) | [327](/filings/0001163370-26-000029.md) | [336](/filings/0001163370-26-000029.md) | [348](/filings/0001163370-26-000029.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.4 d](/filings/0001163370-24-000037.md) | [49.9 d](/filings/0001163370-26-000007.md) | [(5.5)](/filings/0001163370-25-000017.md) | [(38.5) d](/filings/0001163370-25-000029.md) | [(0.2) d](/filings/0001163370-25-000043.md) | [35.5 d](/filings/0001163370-26-000007.md) | [16.5](/filings/0001163370-26-000021.md) | [(4.4) d](/filings/0001163370-26-000029.md) | [92.7 d](/filings/0001163370-25-000043.md) | [34.5 d](/filings/0001163370-26-000007.md) | [27.2](/filings/0001163370-26-000021.md) | [40.1 d](/filings/0001163370-26-000029.md) |
| Capital expenditure | $m | [2.2 d](/filings/0001163370-24-000037.md) | [0.6 d](/filings/0001163370-26-000007.md) | [1.0](/filings/0001163370-25-000017.md) | [0.9 d](/filings/0001163370-25-000029.md) | [0.1 d](/filings/0001163370-25-000043.md) | [(1.4) d](/filings/0001163370-26-000007.md) | [0.2](/filings/0001163370-26-000021.md) | [0.3 d](/filings/0001163370-26-000029.md) | [2.7 d](/filings/0001163370-25-000043.md) | [2.2 d](/filings/0001163370-26-000007.md) | [2.9](/filings/0001163370-26-000021.md) | [0.6 d](/filings/0001163370-26-000029.md) |
| Dividends paid | $m | [3.3 d](/filings/0001163370-24-000037.md) | [3.5 d](/filings/0001163370-26-000007.md) | [3.4](/filings/0001163370-25-000017.md) | [3.4 d](/filings/0001163370-25-000029.md) | [3.4 d](/filings/0001163370-25-000043.md) | [3.6 d](/filings/0001163370-26-000007.md) | [3.5](/filings/0001163370-26-000021.md) | [3.5 d](/filings/0001163370-26-000029.md) | [3.5 d](/filings/0001163370-25-000043.md) | [3.9 d](/filings/0001163370-26-000007.md) | [3.6](/filings/0001163370-26-000021.md) | [3.6 d](/filings/0001163370-26-000029.md) |
| Share repurchases | $m | [2.7 d](/filings/0001163370-24-000037.md) | [2.5 d](/filings/0001163370-26-000007.md) | [0.8](/filings/0001163370-25-000017.md) | [0.0 d](/filings/0001163370-25-000029.md) | [0.0 d](/filings/0001163370-25-000043.md) | [0.0 d](/filings/0001163370-26-000007.md) | [0.0](/filings/0001163370-25-000017.md) | [0.0 d](/filings/0001163370-25-000029.md) | [0.0 d](/filings/0001163370-25-000043.md) | [0.0 d](/filings/0001163370-26-000007.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.7](/filings/0001163370-23-000049.md) | [5.8](/filings/0001163370-24-000026.md) | [5.7](/filings/0001163370-24-000032.md) | [5.6](/filings/0001163370-24-000037.md) | [5.6](/filings/0001163370-25-000017.md) | [5.6](/filings/0001163370-25-000029.md) | [22.3](/filings/0001163370-25-000043.md) | [22.4](/filings/0001163370-26-000021.md) | [22.4](/filings/0001163370-26-000029.md) | [22.5](/filings/0001163370-25-000043.md) | [22.6](/filings/0001163370-26-000021.md) | [22.5](/filings/0001163370-26-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,244,766 at 2026-07-31, from the cover of the [10-Q filed 2026-07-31](/filings/0001163370-26-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.